Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01186133 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice

Study acronym: IRIS-DES
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Jun 10, 2025, no change to tracked fieldsv17-v18
  2. Primary and study completion dates: Dec 2025 to Dec 2030
    • Study arms: 26 to 27
    v16
  3. Enrollment target: 40000 to 50000
    • Study arms: 25 to 26
    v15
  4. Study arms: 24 to 25v14
  5. Re-verified, no change to tracked fieldsv13
Show 11 earlier versionsHide 11 earlier versions
  1. Secondary endpoints: 5 to 6
    • Primary endpoint revised
    v12
  2. Study arms: 23 to 24v11
  3. Study arms: 22 to 23v10
  4. Study arms: 21 to 22v9
  5. Enrollment target: 25000 to 40000
    • Site details revised
    • Study arms: 19 to 21
    v8
  6. Re-verified, no change to tracked fieldsv7
  7. Primary completion date: Dec 2020 to Dec 2025
    • Study completion date: Dec 2021 to Dec 2025
    • Site contact updated
    • Study arms: 16 to 19
    v6
  8. Primary completion date: Dec 2015 to Dec 2020v5 Show 6 more changesShow less
    • Enrollment target: 18600 to 25000
    • Study sites: 53 to 1
    • Study completion date: Dec 2018 to Dec 2021
    • Secondary endpoints: details revised at 4 of 5 entries
    • Study description shortened, about 13 words
    • Study arms: 9 to 16
  9. Trial status: Terminated to Recruitingv4 Show 5 more changesShow less
    • Enrollment target: 11000 to 18600
    • Primary completion date: Dec 2011 to Dec 2015
    • Study sites: 35 to 53
    • Study completion date: Dec 2015 to Dec 2018
    • Study arms: 7 to 9
  10. Lead sponsor: CardioVascular Research Foundation, Korea to Seung-Jung Park
    • Study description expanded, about 24 words
    • Collaborators expanded, about 4 words
    v3
  11. Trial status: Recruiting to Terminated Sponsor's reason: This study has been separated individually per each stent.
    • Study sites: 37 to 35
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Trial Details
NCT Number NCT01186133
Lead Sponsor Seung-Jung Park
Collaborators: CardioVascular Research Foundation, Korea
Conditions
(from sponsor)		 Coronary Artery Disease, Percutaneous Transluminal Coronary Angioplasty
Related terms Coronary Artery Disease, Coronary Disease
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov